Larvol Delta - A-Phase-I-Openlabel-Multicenter-Study-to-Evaluate-the-Safety-and-Tolerability-of-BP2202-in-Patients-With-RelapsedRefractory-Multiple-Myeloma

BP2202 - BrightPath Biotherap

http://clinicaltrials.gov/ct2/show/NCT07667868

Jun 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next